Predictors of influenza vaccination in HIV-infected patients in the United States, 1990-2002

Journal of Infectious Diseases

Volumn 196, Issue 3, 2007, Pages 339-346

  Gallagher, Kathleen M ^a,b,c   Juhasz, Marta ^a,b   Harris, Norma S ^a,b,d   Teshale, Eyasu H ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Solar Consulting   (Romania)

^d NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CD4 LYMPHOCYTE COUNT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA VACCINATION; MEDICAL RECORD; PREDICTION; PRIORITY JOURNAL; UNITED STATES; VIRUS LOAD;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 34447618790     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/519165     Document Type: Article

References (32)

1. Treanor JJ. Influenza virus. In: Mandel GL, Bennett IE, Dolin R, eds. Principles and practice of infectious diseases. 5th ed. Vol 2. Philadelphia: Churchill Livingstone, 2000:1823-49.
2. Oxford JS. Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology. Rev Med Virol 2000; 10:119-33
3. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333-40.
4. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-86.
5. Francis T Jr, Salk JE, Pearson HE, Brown PN. Protective effect of vaccination against influenza A. Proc Soc Exp Biol Med 1944; 55:104-5.
6. Francis T Jr, Pearson HE, Salk JE, Brown PN. Immunity in human subjects artificially intected with influenza virus type B. Am J Pub Health 1944; 34:317-34.
7. Advisory Committee on Immunization Practices, Smith, NM, Bresee JS, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55:1-42.
8. Centers for Disease Control and Prevention. Prevention and Control of Influenza; Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 1991; 40:1-15.
9. Centers for Disease Control and Prevention. USPHS/1DSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. MMWR Recomm Rep 1995; 44:1-34.
10. Centers for Disease Control and Prevention. Influenza vaccination and self-reported reasons for not receiving vaccination among Medicare beneficiaries aged >65 years - United States, 1991-2002. MMWR Morb Mortal Wkly Rep 2004; 53(43):1012-5.
11. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination coverage among persons aged >65 years and persons aged 18-64 years with diabetes or asthma - United States, 2003. MMWR Morb Mortal Wkly Rep 2004; 53(43):1007-12.
12. Centers for Disease Control and Prevention (CDC). National Health Interview Survey - 2002. Hyattsville, MD: US Department of Health and Human Services, CDC, National Center for Health Statistics, 2002. Available at: http://www.cdc.gov/nchs/about/major/nhis/quest_data_related. Accessed 15 March 2006.
13. US Department of Health and Human Services. Healthy People 2010: understanding and improving health. 2nd ed. Washington, DC, US Department of Health and Human Services, 2000. Available at: http://www.health.gov/ healthypeople. Accessed 15 March 2006.
14. Wortley PM, Farizo K. ASD Project Group. Pneumococcal and influenza vaccination levels among HIV-infected adolescents and adults receiving medical care in the United States. AIDS 1994; 8:941-4.
15. Sorvillo FJ, Nahlen BL. Influenza immunization for HIV-infected persons in Los Angeles. Vaccine 1995; 13:377-80.
16. Farizo KM, Buehler JW, Chamberland ME, et al. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA 1992; 267:1798-805.
17. Centers for Disease Control and Prevention. HIV/AIDS Surveill Rep 2004; 16:42-3. Available at: http://www.cdc.gov/hiv/stats/hasrlink.htm. Accessed 2 August 2006.
18. Centers for Disease Control and Prevention. HIV/AIDS Surveill Rep 2002; 14:30. Also available at: http://www.cdc.gov/hiv/stats/hasrlink. htm. Accessed 2 August 2006.
19. Montaner JS, Phillips P, Zala C, Craib KJ, O'Shaughnessy MV, Schechter MT. Adherence to guidelines for the prevention of HIV-related respiratory diseases. Eur Respir J 1996; 9: 2318-22.
20. Singleton JA, Greby SM, Wooten KG, Walker FJ, Strikas R. Influenza, pneumococcal, and tetanus toxoid vaccination of adults - United States, 1993-1997. MMWR CDC Surveill Summ 2000; 49:39-62.
21. Willis BC, Ndiaye SM, Hopkins DP, Shefer A. Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged < 65 years at high risk: A report on recommendations of the Task Force on Community Preventive Services. MMWR Recomm Rep 2005; 54:1-11.
22. Centers for Disease Control and Prevention. Influenza and pneumococal vaccine coverage among persons aged >54 years and persons aged 18-64 years with diabetes or asthma. MMWR Morb Mortal Wkly Rep 2004; 53(43):1007-12.
23. O'Brien W A, Grovit-Ferbas K, Namazi A, et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995; 86: 1082-9.
24. Staprans SI, Hamilton BL, Follansbee SE, et al. Activation of virus replication after vaccination of HIV-infected individuals. J Exp Med 1995; 182:1727-37.
25. Kamal KM, Madhavan SS, Amonkar MM. Determinant of adult influenza and pneumonia immunization rates. J Am Pharm Assoc 2003; 43:403-11.
26. Pena-Rey I, Perez-Farinos N, Sarria-Santamera A. Factors associated with influenza vaccination among elderly Spanish women. Public Health 2004; 118:582-7.
27. Kroon FP, van Dissel JT, Jong JC, van Firth R. Antibody response to influenza, tetanus, and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS 1994; 8:469-76.
28. Fowke KR, D'Amico R, Chernoff D, et al. Immunologic and virologic evaluations after influenza vaccination of HIV-1 infected patients. AIDS 1997; 11:1013-21.
29. Fuller JD, Craven DE, Steger KA, Cox N, Heeren TC, Chernoff D. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clin Infect Dis 1999; 28:541-7.
30. Tacken M, Braspenning J, Spreeuwenberg P, et al. Patient characteristics determine differences in the influenza vaccination rate more so than practice features. Prev Med 2002; 35:401-6.
31. Sullivan PS, Hanson DL, Dworkin MS, Jones JL, Ward JW. Effects of influenza vaccination on disease progression among HIV-infected persons. AIDS 2000; 14:2781-5.
32. Tasker SA, Treanor JJ, Paxton WB, Wallace MR. Efficacy of influenza vaccination in HIV-infected persons: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999; 131:430-3.